SEC reporting owner

Sethuraman Natarajan SEC insider disclosures

Explore Sethuraman Natarajan's reporting-owner identity, issuer relationships, purchases, sales and SEC filing receipts.

As of 2026-10-07T00:29:11.873Z

Reporting owner CIK
0001873394
Issuers
1
Coverage
verified

Issuer relationships

A reporting-owner CIK identifies the filer across issuer relationships and name aliases. A filer may be an individual or an organization; the filing role is the relevant evidence.

Entrada Therapeutics, Inc.0001689375TRDAYesNo

Recent SEC transactions

Code P identifies a purchase, S a sale and A an award. Awards and open-market purchases describe different events. Use the public availability date when deciding when a researcher could have known about the transaction.

2026-05-052026-05-04TRDAS25,907Not reported
2026-03-042026-03-01TRDAA55,800Not reported
2026-03-042026-03-01TRDAA83,200Not reported
2025-03-052025-03-01TRDAA60,800Not reported
2025-03-052025-03-01TRDAA90,800Not reported
2024-12-042024-12-03TRDAS11,703Not reported
2024-12-042024-12-02TRDAS4,088Not reported
2024-12-042024-11-29TRDAS100Not reported
2024-11-142024-11-13TRDAS2,700Not reported
2024-11-142024-11-11TRDAS1,409Not reported
2024-11-072024-11-06TRDAS2,745Not reported
2024-11-072024-11-06TRDAS9,554Not reported
2024-11-072024-11-05TRDAS5,171Not reported
2024-11-072024-11-04TRDAS749Not reported
2024-10-192024-10-16TRDAS600Not reported

Up to 50 transactions from the recent two-year owner window.

Source evidence and strategy eligibility

The transactions below come from filings; a historical tracker separately simulates following eligible events. Joint filers can report the same transaction, and an owner can have filings at multiple companies. Public availability, amendment lineage and verified coverage determine which events a historical tracker may use.

The current directory marks this owner's filing coverage verified.